Hansoh Pharmaceutical Group Co., Ltd.
Hansoh Pharmaceutical Group Co., Ltd. has 1 licensing announcement in this dataset, dated 2026-10-19.
- Country / operating region
- China
- Ticker
- 03692.HK
- Headquarters
- China
- Founded
- 查無
- Business
- Pharmaceutical research, development, manufacturing and commercialization
- Website
- www.hspharm.com
Pipeline / products
| Asset / platform | Target | Modality | Stage at announcement | Announcement date |
|---|---|---|---|---|
| Two preclinical ADC programs; additional collaboration ADC programs | 查無 | ADC | preclinical | 2026-10-19 |
| Asset | Registered / announced phase | Trial | Status | Sponsor | Record date |
|---|---|---|---|---|---|
| HS-20089 | PHASE3 | NCT07821606 | NOT_YET_RECRUITING | Hansoh BioMedical R&D Company | 2026-09-16 |
Licensing deals
| Date | Counterparty | Asset / platform | Upfront | Near-term | Milestones | Potential total | Other disclosed terms |
|---|---|---|---|---|---|---|---|
| 2026-10-19 | Roche | Two preclinical ADC programs; additional collaboration ADC programs | USD 400m | USD 110m First anniversary | > USD 15000m | 查無 | — |
| Counterparty | Territory | Royalties |
|---|---|---|
| Roche | Worldwide excluding mainland China, Hong Kong, Macau and Taiwan | Tiered royalties on future product sales. |
Asia ADC assets and licensing deals
Catalysts
查無
Latest monthly revenue
查無
Most advanced drug
查無